Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists

The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the β-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 51; pp. 184 - 192
Main Authors Wijtmans, Maikel, Maussang, David, Sirci, Francesco, Scholten, Danny J., Canals, Meritxell, Mujić-Delić, Azra, Chong, Milagros, Chatalic, Kristell L.S., Custers, Hans, Janssen, Elwin, de Graaf, Chris, Smit, Martine J., de Esch, Iwan J.P., Leurs, Rob
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 01.05.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the β-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate the pharmacology and the therapeutic potential of CXCR7. In the present study, we synthesized 24 derivatives based on a compound scaffold patented by Chemocentryx and obtained CXCR7 ligands with pKi values ranging from 5.3 to 8.1. SAR studies were supported by computational 3D Fingerprint studies, revealing several important affinity descriptors. Two key compounds (29 and 30, VUF11207 and VUF11403) were found to be high-potency ligands that induce recruitment of β-arrestin2 and subsequent internalization of CXCR7, making them important tool compounds in future CXCR7 research. [Display omitted] ► Substituted styrene-amides are excellent CXCR7 binders. ► Computational model suggests important molecular descriptors. ► Key compounds induce recruitment of β-arrestin2 to CXCR7. ► Key compounds induce CXCR7 internalization.
AbstractList The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the β-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate the pharmacology and the therapeutic potential of CXCR7. In the present study, we synthesized 24 derivatives based on a compound scaffold patented by Chemocentryx and obtained CXCR7 ligands with pKi values ranging from 5.3 to 8.1. SAR studies were supported by computational 3D Fingerprint studies, revealing several important affinity descriptors. Two key compounds (29 and 30, VUF11207 and VUF11403) were found to be high-potency ligands that induce recruitment of β-arrestin2 and subsequent internalization of CXCR7, making them important tool compounds in future CXCR7 research. [Display omitted] ► Substituted styrene-amides are excellent CXCR7 binders. ► Computational model suggests important molecular descriptors. ► Key compounds induce recruitment of β-arrestin2 to CXCR7. ► Key compounds induce CXCR7 internalization.
The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the beta-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate the pharmacology and the therapeutic potential of CXCR7. In the present study, we synthesized 24 derivatives based on a compound scaffold patented by Chemocentryx and obtained CXCR7 ligands with pK(i) values ranging from 5.3 to 8.1. SAR studies were supported by computational 3D Fingerprint studies, revealing several important affinity descriptors. Two key compounds (29 and 30, VUF11207 and VUF11403) were found to be high-potency ligands that induce recruitment of beta-arrestin2 and subsequent internalization of CXCR7, making them important tool compounds in future CXCR7 research. (C) 2012 Elsevier Masson SAS. All rights reserved.
The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the β-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate the pharmacology and the therapeutic potential of CXCR7. In the present study, we synthesized 24 derivatives based on a compound scaffold patented by Chemocentryx and obtained CXCR7 ligands with pK(i) values ranging from 5.3 to 8.1. SAR studies were supported by computational 3D Fingerprint studies, revealing several important affinity descriptors. Two key compounds (29 and 30, VUF11207 and VUF11403) were found to be high-potency ligands that induce recruitment of β-arrestin2 and subsequent internalization of CXCR7, making them important tool compounds in future CXCR7 research.
Author Smit, Martine J.
Leurs, Rob
Wijtmans, Maikel
Mujić-Delić, Azra
Scholten, Danny J.
Maussang, David
Chatalic, Kristell L.S.
Sirci, Francesco
Custers, Hans
Chong, Milagros
Canals, Meritxell
de Esch, Iwan J.P.
de Graaf, Chris
Janssen, Elwin
Author_xml – sequence: 1
  givenname: Maikel
  surname: Wijtmans
  fullname: Wijtmans, Maikel
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 2
  givenname: David
  surname: Maussang
  fullname: Maussang, David
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 3
  givenname: Francesco
  surname: Sirci
  fullname: Sirci, Francesco
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 4
  givenname: Danny J.
  surname: Scholten
  fullname: Scholten, Danny J.
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 5
  givenname: Meritxell
  surname: Canals
  fullname: Canals, Meritxell
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 6
  givenname: Azra
  surname: Mujić-Delić
  fullname: Mujić-Delić, Azra
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 7
  givenname: Milagros
  surname: Chong
  fullname: Chong, Milagros
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 8
  givenname: Kristell L.S.
  surname: Chatalic
  fullname: Chatalic, Kristell L.S.
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 9
  givenname: Hans
  surname: Custers
  fullname: Custers, Hans
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 10
  givenname: Elwin
  surname: Janssen
  fullname: Janssen, Elwin
  organization: Department of Chemistry & Pharmaceutical Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 11
  givenname: Chris
  surname: de Graaf
  fullname: de Graaf, Chris
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 12
  givenname: Martine J.
  surname: Smit
  fullname: Smit, Martine J.
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 13
  givenname: Iwan J.P.
  surname: de Esch
  fullname: de Esch, Iwan J.P.
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
– sequence: 14
  givenname: Rob
  surname: Leurs
  fullname: Leurs, Rob
  email: r.leurs@vu.nl
  organization: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25868195$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22424612$$D View this record in MEDLINE/PubMed
BookMark eNqNkV2L1TAQhoOsuGdX_4FIbgRBe0zSpB83ghS_YEHwA7wraTrZTUmTtZOunH9vDj2udyIMZC6eJ5m8c0HOQgxAyFPO9pzx6vW0h2kGc7MXjIs9yyX5A7LjddUUpVDyjOyYEGWhRCnPyQXixBhTFWOPyLkQUsiKix2Zvh5CugF0-IrOcQTvwjXVYaR2DSa5GLSnOjd3Lh1otBTXAZNLa4KRYjosEKDQsxsBqUaKs_a-mKMHs3qg3Y_uS031dQwOEz4mD632CE9O5yX5_v7dt-5jcfX5w6fu7VVhpGpSnle0gzZsEK1sjGCDFcpUzDDT2lHpUvOxNbWthYWaVUwOStUSytYMdSukFuUlebHde7vEnytg6meHBrzXAeKKfU6PyUZJWWZUbqhZIuICtr9d3KyXQ4aOXNVP_ZZyf0y5Z7kkz9qz0wvrMMN4L_2JNQPPT4BGo71ddDAO_3KqqRreqsy93LhfMESLxkEwcI_lfZVMipa3ueNNppv_pzuX9HF_XVxDyuqbTYUc_J2DpT_po1vApH6M7t9f_g20Jr_c
CODEN EJMCA5
CitedBy_id crossref_primary_10_3390_ph13020033
crossref_primary_10_1021_acsmedchemlett_0c00163
crossref_primary_10_1126_scisignal_aaw3657
crossref_primary_10_21597_jist_843369
crossref_primary_10_1038_s41467_023_40482_9
crossref_primary_10_1074_jbc_M113_498436
crossref_primary_10_1016_j_bmcl_2021_128320
crossref_primary_10_1002_ejoc_202100761
crossref_primary_10_1021_acs_joc_7b02351
crossref_primary_10_4155_fmc_13_194
crossref_primary_10_1016_j_nucmedbio_2024_108906
crossref_primary_10_3389_fendo_2022_906586
crossref_primary_10_1007_s00018_024_05158_7
crossref_primary_10_1016_j_mce_2019_01_021
crossref_primary_10_1111_bph_14132
crossref_primary_10_1021_bi501526s
crossref_primary_10_1016_j_pharmthera_2021_108014
crossref_primary_10_1021_acs_jmedchem_8b00190
crossref_primary_10_1111_bph_12117
crossref_primary_10_3390_cells11020213
crossref_primary_10_3389_fncel_2014_00144
crossref_primary_10_3390_cells11081317
crossref_primary_10_1016_j_cellsig_2020_109862
crossref_primary_10_3390_molecules25102364
crossref_primary_10_3892_ijo_2014_2547
crossref_primary_10_1021_acs_jmedchem_7b01028
crossref_primary_10_1021_acsmedchemlett_3c00469
crossref_primary_10_1124_mol_119_117663
crossref_primary_10_1002_chin_201238215
crossref_primary_10_1016_j_bcp_2013_08_019
crossref_primary_10_1126_sciadv_abn8063
crossref_primary_10_1210_endocr_bqac081
crossref_primary_10_1371_journal_pone_0146503
crossref_primary_10_1016_j_str_2024_04_018
crossref_primary_10_1021_acs_jmedchem_2c01198
crossref_primary_10_1016_j_heliyon_2018_e00557
crossref_primary_10_1186_s13041_021_00862_y
crossref_primary_10_1021_acscentsci_9b00224
crossref_primary_10_1124_molpharm_121_000295
crossref_primary_10_1124_molpharm_123_000835
crossref_primary_10_1016_j_bbrc_2022_01_030
crossref_primary_10_1074_jbc_M114_568287
crossref_primary_10_1182_blood_2021013097
crossref_primary_10_3892_mmr_2022_12594
crossref_primary_10_1039_C2SC21524A
crossref_primary_10_1021_acs_orglett_8b02261
crossref_primary_10_3389_fphar_2018_00641
crossref_primary_10_1021_jm400307y
Cites_doi 10.1074/jbc.M707465200
10.1124/mol.108.053389
10.1073/pnas.1012865107
10.1074/jbc.M111.277038
10.1111/j.1600-0609.2010.01531.x
10.1038/nri3049
10.1124/jpet.111.179622
10.1073/pnas.0610444104
10.1186/1476-4598-10-73
10.1074/jbc.C110.147470
10.1084/jem.20052144
10.4049/jimmunol.0900269
10.1016/j.ejca.2011.06.044
10.1189/jlb.0208088
10.1158/0008-5472.CAN-09-3642
10.1021/ci600253e
10.1073/pnas.0912852107
10.1016/j.joca.2006.01.007
10.1074/jbc.M508234200
10.1038/nrd3024
10.1021/ja00141a004
10.1021/jo00344a013
10.1021/jm00145a002
10.1021/ci700018y
ContentType Journal Article
Copyright 2012 Elsevier Masson SAS
2015 INIST-CNRS
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Masson SAS
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 Elsevier Masson SAS. All rights reserved.
DBID 1KM
BLEPL
DTL
GKHJH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ejmech.2012.02.041
DatabaseName Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 2012
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
Web of Science
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1768-3254
EndPage 192
ExternalDocumentID 10_1016_j_ejmech_2012_02_041
22424612
25868195
000304291900018
S0223523412001328
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Dutch Top Institute Pharma
  grantid: D1.105
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JN
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
M2Y
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCB
SCC
SDF
SDG
SES
SEW
SOC
SPC
SPCBC
SPT
SSK
SSP
SSU
SSZ
T5K
WUQ
~G-
1KM
AAXKI
AKRWK
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
AALMO
AAPBV
ABFLS
ABPIF
ABPTK
ABQIS
ADALY
IPNFZ
IQODW
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c458t-5229bac0b2948c20bf25c60c0c9fd5a3a1d9c7f72fe70604b5574e39cb7924a23
IEDL.DBID .~1
ISICitedReferencesCount 49
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000304291900018
ISSN 0223-5234
IngestDate Fri Aug 16 08:43:25 EDT 2024
Thu Sep 26 18:17:17 EDT 2024
Sat Sep 28 08:35:27 EDT 2024
Thu Nov 24 18:35:13 EST 2022
Tue Sep 17 21:56:26 EDT 2024
Fri Sep 27 16:39:13 EDT 2024
Fri Feb 23 02:33:48 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords BRET
Agonist
RT
YFP
Ligand
EDCI
LDA
β-arrestin2
CXCR7
Cm
MIF
RLuc
CzH
FLAP
Internalization
HOBT
GPCR
NOESY
3D fingerprint
HBSS
ELISA
ERK
MIGRATION
RDC1
CHEMOKINE RECEPTOR CXCR7
beta-arrestin2
Language English
License CC BY 4.0
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c458t-5229bac0b2948c20bf25c60c0c9fd5a3a1d9c7f72fe70604b5574e39cb7924a23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1969-0238
0000-0001-6822-9950
0000-0003-2713-0238
0000-0002-1226-2150
0000-0002-7942-5006
PMID 22424612
PQID 1010485443
PQPubID 23479
PageCount 9
ParticipantIDs webofscience_primary_000304291900018
proquest_miscellaneous_1010485443
pubmed_primary_22424612
elsevier_sciencedirect_doi_10_1016_j_ejmech_2012_02_041
pascalfrancis_primary_25868195
crossref_primary_10_1016_j_ejmech_2012_02_041
webofscience_primary_000304291900018CitationCount
PublicationCentury 2000
PublicationDate 2012-05-01
PublicationDateYYYYMMDD 2012-05-01
PublicationDate_xml – month: 05
  year: 2012
  text: 2012-05-01
  day: 01
PublicationDecade 2010
PublicationPlace ISSY-LES-MOULINEAUX
PublicationPlace_xml – name: ISSY-LES-MOULINEAUX
– name: Kidlington
– name: France
PublicationTitle European journal of medicinal chemistry
PublicationTitleAbbrev EUR J MED CHEM
PublicationTitleAlternate Eur J Med Chem
PublicationYear 2012
Publisher Elsevier Masson SAS
Elsevier
Publisher_xml – name: Elsevier Masson SAS
– name: Elsevier
References Lögers, Overman, Welmaker (bib19) 1995; 117
Zabel, Lewen, Berahovich, Jaen, Schall (bib26) 2011; 10
A. Melikian, J. Burns, B.E. McMaster, T. Schall, J.J. Wright, Inhibitors of human tumor-expressed CCXCKR2, WO20041058705 A2 (2004).
Goodwin, Ratcliff, Crowder, Seitzinger (bib18) 1982; 47
Hattermann, Held-Feindt, Lucius, Muerkoster, Penfold, Schall, Mentlein (bib8) 2010; 70
Milletti, Storchi, Sforna, Cruciani (bib28) 2007; 47
Goodford (bib21) 1985; 28
Zabel, Wang, Lewen, Berahovich, Penfold, Zhang, Powers, Summers, Miao, Zhao, Jalili, Janowska-Wieczorek, Jaen, Schall (bib14) 2009; 183
Rajagopal, Kim, Ahn, Craig, Lam, Gerard, Gerard, Lefkowitz (bib4) 2009; 107
Kalatskaya, Berchiche, Gravel, Limberg, Rosenbaum, Heveker (bib11) 2009; 75
Burns, Summers, Wang, Melikian, Berahovich, Miao, Penfold, Sunshine, Littman, Kuo, Wei, McMaster, Wright, Howard, Schall (bib3) 2006; 203
Miao, Luker, Summers, Berahovich, Bhojani, Rehemtulla, Kleer, Essner, Nasevicius, Luker, Howard, Schall (bib6) 2007; 104
Jones, Brockbank, Mobbs, Le Good, Soma-Haddrick, Heuze, Langham, Timms, Newham, Needham (bib10) 2006; 14
J. Burns, B. Summers, Y. Wang, M. Howard, T. Schall, Z. Miao, Methods and compositions for modulating angiogenesis, US 20050214287 A1 (2005).
Rajagopal, Rajagopal, Lefkowitz (bib23) 2010; 9
Ferain, Hoveyda, Ooms, Schols, Bernard, Fraser (bib25) 2011; 337
Decaillot, Kazmi, Lin, Ray-Saha, Sakmar, Sachdev (bib27) 2011; 286
L. Cruz-Orengo, Y.J. Chen, J.H. Kim, D. Dorsey, S.K. Song, R.S. Klein, CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity, J. Neuroinflammation
Baroni, Cruciani, Sciabola, Perruccio, Mason (bib20) 2007; 47
Jahnichen, Blanchetot, Maussang, Gonzalez-Pajuelo, Chow, Bosch, De Vrieze, Serruys, Ulrichts, Vandevelde, Saunders, De Haard, Schols, Leurs, Vanlandschoot, Verrips, Smit (bib29) 2010; 107
Gravel, Malouf, Boulais, Berchiche, Oishi, Fujii, Leduc, Sinnett, Heveker (bib12) 2011; 285
Hartmann, Grabovsky, Pasvolsky, Shulman, Buss, Spiegel, Nagler, Lapidot, Thelen, Alon (bib13) 2008; 84
Balabanian, Lagane, Infantino, Chow, Harriague, Moepps, Arenzana-Seisdedos, Thelen, Bachelerie (bib2) 2005; 280
bib22
.
Adachi, Chiba (bib24) 2008; 1
Monnier, Boissan, L’Helgoualc’h, Lacombe, Turlin, Zucman-Rossi, Theret, Piquet-Pellorce, Samson (bib5) 2012; 48
Tarnowski, Liu, Wysoczynski, Ratajczak, Kucia, Ratajczak (bib9) 2010; 85
Zlotnik, Burkhardt, Homey (bib1) 2011; 11
Wang, Shiozawa, Wang, Jung, Pienta, Mehra, Loberg, Taichman (bib7) 2008; 283
Monnier, J (WOS:000299866200018) 2012; 48
Wang, JH (WOS:000253083500063) 2008; 283
LOGERS, M (WOS:A1995RU81800004) 1995; 117
Kalatskaya, I (WOS:000265444800024) 2009; 75
Zabel, BA (WOS:000292200400001) 2011; 10
Gravel, S (WOS:000284625600001) 2010; 285
(000304291900018.1) 2005
Hattermann, K (WOS:000278486100035) 2010; 70
GOODFORD, PJ (WOS:A1985AKX8400002) 1985; 28
Jahnichen, S (WOS:000284529000076) 2010; 107
Cruz-Orengo, L. (000304291900018.7) 1000
Milletti, F (WOS:000251216500015) 2007; 47
Tarnowski, M (WOS:000284165600002) 2010; 85
Rajagopal, S (WOS:000273559300022) 2010; 107
Adachi, K (WOS:000215778600002) 2007; 1
Rajagopal, S (WOS:000277170200023) 2010; 9
Hartmann, TN (WOS:000259639500030) 2008; 84
Balabanian, K (WOS:000232561200079) 2005; 280
Zabel, BA (WOS:000269391400038) 2009; 183
Decaillot, FM (WOS:000294726800029) 2011; 286
Baroni, M (WOS:000245136100004) 2007; 47
(000304291900018.2) 2004
Burns, JM (WOS:000240288000022) 2006; 203
Miao, Z (WOS:000249942700027) 2007; 104
Ferain, T (WOS:000290618000010) 2011; 337
GOODWIN, TE (WOS:A1982NE34600013) 1982; 47
Jones, SW (WOS:000238465300012) 2006; 14
Zlotnik, A (WOS:000294250400003) 2011; 11
Miao (10.1016/j.ejmech.2012.02.041_bib6) 2007; 104
Hattermann (10.1016/j.ejmech.2012.02.041_bib8) 2010; 70
Lögers (10.1016/j.ejmech.2012.02.041_bib19) 1995; 117
10.1016/j.ejmech.2012.02.041_bib16
10.1016/j.ejmech.2012.02.041_bib15
Goodwin (10.1016/j.ejmech.2012.02.041_bib18) 1982; 47
10.1016/j.ejmech.2012.02.041_bib17
Baroni (10.1016/j.ejmech.2012.02.041_bib20) 2007; 47
Gravel (10.1016/j.ejmech.2012.02.041_bib12) 2011; 285
Kalatskaya (10.1016/j.ejmech.2012.02.041_bib11) 2009; 75
Adachi (10.1016/j.ejmech.2012.02.041_bib24) 2008; 1
Decaillot (10.1016/j.ejmech.2012.02.041_bib27) 2011; 286
Monnier (10.1016/j.ejmech.2012.02.041_bib5) 2012; 48
Jones (10.1016/j.ejmech.2012.02.041_bib10) 2006; 14
Jahnichen (10.1016/j.ejmech.2012.02.041_bib29) 2010; 107
Rajagopal (10.1016/j.ejmech.2012.02.041_bib23) 2010; 9
Burns (10.1016/j.ejmech.2012.02.041_bib3) 2006; 203
Goodford (10.1016/j.ejmech.2012.02.041_bib21) 1985; 28
Rajagopal (10.1016/j.ejmech.2012.02.041_bib4) 2009; 107
Zlotnik (10.1016/j.ejmech.2012.02.041_bib1) 2011; 11
Balabanian (10.1016/j.ejmech.2012.02.041_bib2) 2005; 280
Milletti (10.1016/j.ejmech.2012.02.041_bib28) 2007; 47
Zabel (10.1016/j.ejmech.2012.02.041_bib26) 2011; 10
Tarnowski (10.1016/j.ejmech.2012.02.041_bib9) 2010; 85
Hartmann (10.1016/j.ejmech.2012.02.041_bib13) 2008; 84
Wang (10.1016/j.ejmech.2012.02.041_bib7) 2008; 283
Zabel (10.1016/j.ejmech.2012.02.041_bib14) 2009; 183
Ferain (10.1016/j.ejmech.2012.02.041_bib25) 2011; 337
References_xml – volume: 104
  start-page: 15735
  year: 2007
  end-page: 15740
  ident: bib6
  article-title: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Schall
– volume: 48
  start-page: 138
  year: 2012
  end-page: 148
  ident: bib5
  article-title: CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells
  publication-title: Eur. J. Cancer
  contributor:
    fullname: Samson
– volume: 107
  start-page: 20565
  year: 2010
  end-page: 20570
  ident: bib29
  article-title: CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Smit
– volume: 10
  start-page: 73
  year: 2011
  ident: bib26
  article-title: The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
  publication-title: Mol. Cancer
  contributor:
    fullname: Schall
– volume: 280
  start-page: 35760
  year: 2005
  end-page: 35766
  ident: bib2
  article-title: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Bachelerie
– volume: 285
  start-page: 37939
  year: 2011
  end-page: 37943
  ident: bib12
  article-title: The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Heveker
– volume: 286
  start-page: 32188
  year: 2011
  end-page: 32197
  ident: bib27
  article-title: CXCR7/CXCR4 heterodimer constitutively recruits {beta}-arrestin to enhance cell migration
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Sachdev
– volume: 11
  start-page: 597
  year: 2011
  end-page: 606
  ident: bib1
  article-title: Homeostatic chemokine receptors and organ-specific metastasis
  publication-title: Nat. Rev. Immunol.
  contributor:
    fullname: Homey
– volume: 1
  start-page: 11
  year: 2008
  end-page: 23
  ident: bib24
  article-title: FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology
  publication-title: Perspect. Medicin. Chem.
  contributor:
    fullname: Chiba
– volume: 183
  start-page: 3204
  year: 2009
  end-page: 3211
  ident: bib14
  article-title: Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands
  publication-title: J. Immunol.
  contributor:
    fullname: Schall
– ident: bib22
– volume: 47
  start-page: 279
  year: 2007
  end-page: 294
  ident: bib20
  article-title: A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application
  publication-title: J. Chem. Inf. Model.
  contributor:
    fullname: Mason
– volume: 203
  start-page: 2201
  year: 2006
  end-page: 2213
  ident: bib3
  article-title: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
  publication-title: J. Exp. Med.
  contributor:
    fullname: Schall
– volume: 84
  start-page: 1130
  year: 2008
  end-page: 1140
  ident: bib13
  article-title: A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells
  publication-title: J. Leukoc. Biol.
  contributor:
    fullname: Alon
– volume: 70
  start-page: 3299
  year: 2010
  end-page: 3308
  ident: bib8
  article-title: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects
  publication-title: Cancer Res.
  contributor:
    fullname: Mentlein
– volume: 337
  start-page: 655
  year: 2011
  end-page: 662
  ident: bib25
  article-title: Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Fraser
– volume: 75
  start-page: 1240
  year: 2009
  end-page: 1247
  ident: bib11
  article-title: AMD3100 is a CXCR7 ligand with allosteric agonist properties
  publication-title: Mol. Pharmacol.
  contributor:
    fullname: Heveker
– volume: 9
  start-page: 373
  year: 2010
  end-page: 386
  ident: bib23
  article-title: Teaching old receptors new tricks: biasing seven-transmembrane receptors
  publication-title: Nat. Rev. Drug Discov.
  contributor:
    fullname: Lefkowitz
– volume: 107
  start-page: 628
  year: 2009
  end-page: 632
  ident: bib4
  article-title: Beta-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Lefkowitz
– volume: 47
  start-page: 2172
  year: 2007
  end-page: 2181
  ident: bib28
  article-title: New and original pKa prediction method using grid molecular interaction fields
  publication-title: J. Chem. Inf. Model.
  contributor:
    fullname: Cruciani
– volume: 283
  start-page: 4283
  year: 2008
  end-page: 4294
  ident: bib7
  article-title: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Taichman
– volume: 85
  start-page: 472
  year: 2010
  end-page: 483
  ident: bib9
  article-title: CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells
  publication-title: Eur. J. Haematol.
  contributor:
    fullname: Ratajczak
– volume: 47
  start-page: 815
  year: 1982
  end-page: 820
  ident: bib18
  article-title: Synthesis of (E)-1-aryl-2-methyl-3-alkyl-2-propen-1-ones via sulfoxide sulfenate ester rearrangements
  publication-title: J. Org. Chem.
  contributor:
    fullname: Seitzinger
– volume: 28
  start-page: 849
  year: 1985
  end-page: 857
  ident: bib21
  article-title: A computational procedure for determining energetically favorable binding sites on biologically important macromolecules
  publication-title: J. Med. Chem.
  contributor:
    fullname: Goodford
– volume: 117
  start-page: 9139
  year: 1995
  end-page: 9150
  ident: bib19
  article-title: Mannich biscyclizations. Total synthesis of (−)-ajmalicine
  publication-title: J. Am. Chem. Soc.
  contributor:
    fullname: Welmaker
– volume: 14
  start-page: 597
  year: 2006
  end-page: 608
  ident: bib10
  article-title: The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover
  publication-title: Osteoarthritis Cartilage
  contributor:
    fullname: Needham
– volume: 283
  start-page: 4283
  year: 2008
  ident: WOS:000253083500063
  article-title: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.M707465200
  contributor:
    fullname: Wang, JH
– volume: 75
  start-page: 1240
  year: 2009
  ident: WOS:000265444800024
  article-title: AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
  publication-title: MOLECULAR PHARMACOLOGY
  doi: 10.1124/mol.108.053389
  contributor:
    fullname: Kalatskaya, I
– volume: 107
  start-page: 20565
  year: 2010
  ident: WOS:000284529000076
  article-title: CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.1012865107
  contributor:
    fullname: Jahnichen, S
– volume: 286
  start-page: 32188
  year: 2011
  ident: WOS:000294726800029
  article-title: CXCR7/CXCR4 Heterodimer Constitutively Recruits beta-Arrestin to Enhance Cell Migration
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.M111.277038
  contributor:
    fullname: Decaillot, FM
– volume: 85
  start-page: 472
  year: 2010
  ident: WOS:000284165600002
  article-title: CXCR7: a new SDF-1-binding receptor in contrast to normal CD34+progenitors is functional and is expressed at higher level in human malignant hematopoietic cells
  publication-title: EUROPEAN JOURNAL OF HAEMATOLOGY
  doi: 10.1111/j.1600-0609.2010.01531.x
  contributor:
    fullname: Tarnowski, M
– volume: 11
  start-page: 597
  year: 2011
  ident: WOS:000294250400003
  article-title: Homeostatic chemokine receptors and organ-specific metastasis
  publication-title: NATURE REVIEWS IMMUNOLOGY
  doi: 10.1038/nri3049
  contributor:
    fullname: Zlotnik, A
– volume: 47
  start-page: 815
  year: 1982
  ident: WOS:A1982NE34600013
  article-title: SYNTHESIS OF (E)-1-ARYL-2-METHYL-3-ALKYL-2-PROPEN-1-ONES VIA ALLYLIC SULFOXIDE-SULFENATE ESTER REARRANGEMENTS
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  contributor:
    fullname: GOODWIN, TE
– volume: 337
  start-page: 655
  year: 2011
  ident: WOS:000290618000010
  article-title: Agonist-Induced Internalization of CC Chemokine Receptor 5 as a Mechanism to Inhibit HIV Replication
  publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
  doi: 10.1124/jpet.111.179622
  contributor:
    fullname: Ferain, T
– volume: 104
  start-page: 15735
  year: 2007
  ident: WOS:000249942700027
  article-title: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.0610444104
  contributor:
    fullname: Miao, Z
– year: 2005
  ident: 000304291900018.1
  publication-title: Methods and compositions for modulating angiogenesis
– volume: 1
  start-page: 11
  year: 2007
  ident: WOS:000215778600002
  article-title: FTY720 Story. Its Discovery and the Following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology
  publication-title: PERSPECTIVES IN MEDICINAL CHEMISTRY
  contributor:
    fullname: Adachi, K
– year: 1000
  ident: 000304291900018.7
  article-title: CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity
  publication-title: J. Neuro-inflammation
  contributor:
    fullname: Cruz-Orengo, L.
– volume: 10
  start-page: ARTN 73
  year: 2011
  ident: WOS:000292200400001
  article-title: The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
  publication-title: MOLECULAR CANCER
  doi: 10.1186/1476-4598-10-73
  contributor:
    fullname: Zabel, BA
– volume: 285
  start-page: 37939
  year: 2010
  ident: WOS:000284625600001
  article-title: The Peptidomimetic CXCR4 Antagonist TC14012 Recruits beta-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.C110.147470
  contributor:
    fullname: Gravel, S
– volume: 203
  start-page: 2201
  year: 2006
  ident: WOS:000240288000022
  article-title: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
  publication-title: JOURNAL OF EXPERIMENTAL MEDICINE
  doi: 10.1084/jem.20052144
  contributor:
    fullname: Burns, JM
– volume: 47
  start-page: 2172
  year: 2007
  ident: WOS:000251216500015
  article-title: New and original pK(a) prediction method using grid molecular interaction fields
  publication-title: JOURNAL OF CHEMICAL INFORMATION AND MODELING
  contributor:
    fullname: Milletti, F
– volume: 183
  start-page: 3204
  year: 2009
  ident: WOS:000269391400038
  article-title: Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
  publication-title: JOURNAL OF IMMUNOLOGY
  doi: 10.4049/jimmunol.0900269
  contributor:
    fullname: Zabel, BA
– volume: 48
  start-page: 138
  year: 2012
  ident: WOS:000299866200018
  article-title: CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells
  publication-title: EUROPEAN JOURNAL OF CANCER
  doi: 10.1016/j.ejca.2011.06.044
  contributor:
    fullname: Monnier, J
– volume: 84
  start-page: 1130
  year: 2008
  ident: WOS:000259639500030
  article-title: A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34(+) cells
  publication-title: JOURNAL OF LEUKOCYTE BIOLOGY
  doi: 10.1189/jlb.0208088
  contributor:
    fullname: Hartmann, TN
– volume: 70
  start-page: 3299
  year: 2010
  ident: WOS:000278486100035
  article-title: The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
  publication-title: CANCER RESEARCH
  doi: 10.1158/0008-5472.CAN-09-3642
  contributor:
    fullname: Hattermann, K
– volume: 47
  start-page: 279
  year: 2007
  ident: WOS:000245136100004
  article-title: A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application
  publication-title: JOURNAL OF CHEMICAL INFORMATION AND MODELING
  doi: 10.1021/ci600253e
  contributor:
    fullname: Baroni, M
– year: 2004
  ident: 000304291900018.2
  publication-title: Inhibitors of human tumor-expressed CCXCKR2
– volume: 107
  start-page: 628
  year: 2010
  ident: WOS:000273559300022
  article-title: beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.0912852107
  contributor:
    fullname: Rajagopal, S
– volume: 117
  start-page: 9139
  year: 1995
  ident: WOS:A1995RU81800004
  article-title: MANNICH BISCYCLIZATIONS - TOTAL SYNTHESIS OF (-)-AJMALICINE
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  contributor:
    fullname: LOGERS, M
– volume: 14
  start-page: 597
  year: 2006
  ident: WOS:000238465300012
  article-title: The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover
  publication-title: OSTEOARTHRITIS AND CARTILAGE
  doi: 10.1016/j.joca.2006.01.007
  contributor:
    fullname: Jones, SW
– volume: 280
  start-page: 35760
  year: 2005
  ident: WOS:000232561200079
  article-title: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  doi: 10.1074/jbc.M508234200
  contributor:
    fullname: Balabanian, K
– volume: 28
  start-page: 849
  year: 1985
  ident: WOS:A1985AKX8400002
  article-title: A COMPUTATIONAL-PROCEDURE FOR DETERMINING ENERGETICALLY FAVORABLE BINDING-SITES ON BIOLOGICALLY IMPORTANT MACROMOLECULES
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  contributor:
    fullname: GOODFORD, PJ
– volume: 9
  start-page: 373
  year: 2010
  ident: WOS:000277170200023
  article-title: Teaching old receptors new tricks: biasing seven-transmembrane receptors
  publication-title: NATURE REVIEWS DRUG DISCOVERY
  doi: 10.1038/nrd3024
  contributor:
    fullname: Rajagopal, S
– volume: 75
  start-page: 1240
  year: 2009
  ident: 10.1016/j.ejmech.2012.02.041_bib11
  article-title: AMD3100 is a CXCR7 ligand with allosteric agonist properties
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.108.053389
  contributor:
    fullname: Kalatskaya
– volume: 337
  start-page: 655
  year: 2011
  ident: 10.1016/j.ejmech.2012.02.041_bib25
  article-title: Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.111.179622
  contributor:
    fullname: Ferain
– volume: 85
  start-page: 472
  year: 2010
  ident: 10.1016/j.ejmech.2012.02.041_bib9
  article-title: CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells
  publication-title: Eur. J. Haematol.
  doi: 10.1111/j.1600-0609.2010.01531.x
  contributor:
    fullname: Tarnowski
– volume: 117
  start-page: 9139
  year: 1995
  ident: 10.1016/j.ejmech.2012.02.041_bib19
  article-title: Mannich biscyclizations. Total synthesis of (−)-ajmalicine
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00141a004
  contributor:
    fullname: Lögers
– volume: 47
  start-page: 815
  year: 1982
  ident: 10.1016/j.ejmech.2012.02.041_bib18
  article-title: Synthesis of (E)-1-aryl-2-methyl-3-alkyl-2-propen-1-ones via sulfoxide sulfenate ester rearrangements
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00344a013
  contributor:
    fullname: Goodwin
– volume: 104
  start-page: 15735
  year: 2007
  ident: 10.1016/j.ejmech.2012.02.041_bib6
  article-title: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0610444104
  contributor:
    fullname: Miao
– volume: 70
  start-page: 3299
  year: 2010
  ident: 10.1016/j.ejmech.2012.02.041_bib8
  article-title: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-3642
  contributor:
    fullname: Hattermann
– volume: 10
  start-page: 73
  year: 2011
  ident: 10.1016/j.ejmech.2012.02.041_bib26
  article-title: The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-10-73
  contributor:
    fullname: Zabel
– volume: 28
  start-page: 849
  year: 1985
  ident: 10.1016/j.ejmech.2012.02.041_bib21
  article-title: A computational procedure for determining energetically favorable binding sites on biologically important macromolecules
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00145a002
  contributor:
    fullname: Goodford
– volume: 203
  start-page: 2201
  year: 2006
  ident: 10.1016/j.ejmech.2012.02.041_bib3
  article-title: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20052144
  contributor:
    fullname: Burns
– volume: 11
  start-page: 597
  year: 2011
  ident: 10.1016/j.ejmech.2012.02.041_bib1
  article-title: Homeostatic chemokine receptors and organ-specific metastasis
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3049
  contributor:
    fullname: Zlotnik
– volume: 47
  start-page: 2172
  year: 2007
  ident: 10.1016/j.ejmech.2012.02.041_bib28
  article-title: New and original pKa prediction method using grid molecular interaction fields
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci700018y
  contributor:
    fullname: Milletti
– ident: 10.1016/j.ejmech.2012.02.041_bib17
– volume: 286
  start-page: 32188
  year: 2011
  ident: 10.1016/j.ejmech.2012.02.041_bib27
  article-title: CXCR7/CXCR4 heterodimer constitutively recruits {beta}-arrestin to enhance cell migration
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.277038
  contributor:
    fullname: Decaillot
– ident: 10.1016/j.ejmech.2012.02.041_bib15
– volume: 14
  start-page: 597
  year: 2006
  ident: 10.1016/j.ejmech.2012.02.041_bib10
  article-title: The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2006.01.007
  contributor:
    fullname: Jones
– volume: 48
  start-page: 138
  year: 2012
  ident: 10.1016/j.ejmech.2012.02.041_bib5
  article-title: CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2011.06.044
  contributor:
    fullname: Monnier
– volume: 107
  start-page: 628
  year: 2009
  ident: 10.1016/j.ejmech.2012.02.041_bib4
  article-title: Beta-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0912852107
  contributor:
    fullname: Rajagopal
– volume: 84
  start-page: 1130
  year: 2008
  ident: 10.1016/j.ejmech.2012.02.041_bib13
  article-title: A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0208088
  contributor:
    fullname: Hartmann
– volume: 280
  start-page: 35760
  year: 2005
  ident: 10.1016/j.ejmech.2012.02.041_bib2
  article-title: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M508234200
  contributor:
    fullname: Balabanian
– volume: 107
  start-page: 20565
  year: 2010
  ident: 10.1016/j.ejmech.2012.02.041_bib29
  article-title: CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1012865107
  contributor:
    fullname: Jahnichen
– volume: 283
  start-page: 4283
  year: 2008
  ident: 10.1016/j.ejmech.2012.02.041_bib7
  article-title: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M707465200
  contributor:
    fullname: Wang
– volume: 285
  start-page: 37939
  year: 2011
  ident: 10.1016/j.ejmech.2012.02.041_bib12
  article-title: The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C110.147470
  contributor:
    fullname: Gravel
– volume: 183
  start-page: 3204
  year: 2009
  ident: 10.1016/j.ejmech.2012.02.041_bib14
  article-title: Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900269
  contributor:
    fullname: Zabel
– ident: 10.1016/j.ejmech.2012.02.041_bib16
– volume: 1
  start-page: 11
  year: 2008
  ident: 10.1016/j.ejmech.2012.02.041_bib24
  article-title: FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology
  publication-title: Perspect. Medicin. Chem.
  contributor:
    fullname: Adachi
– volume: 47
  start-page: 279
  year: 2007
  ident: 10.1016/j.ejmech.2012.02.041_bib20
  article-title: A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci600253e
  contributor:
    fullname: Baroni
– volume: 9
  start-page: 373
  year: 2010
  ident: 10.1016/j.ejmech.2012.02.041_bib23
  article-title: Teaching old receptors new tricks: biasing seven-transmembrane receptors
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd3024
  contributor:
    fullname: Rajagopal
SSID ssj0005600
Score 2.2905688
Snippet The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the β-arrestin pathway rather than through G...
The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the beta-arrestin pathway rather than through G...
Source Web of Science
SourceID proquest
crossref
pubmed
pascalfrancis
webofscience
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 184
SubjectTerms 3D fingerprint
Agonist
Amides - chemistry
Biological and medical sciences
Chemistry Techniques, Synthetic
Chemistry, Medicinal
CXCR7
HEK293 Cells
Humans
Internalization
Life Sciences & Biomedicine
Ligand
Medical sciences
Miscellaneous
Models, Molecular
Molecular Conformation
Pharmacology & Pharmacy
Pharmacology. Drug treatments
Quantitative Structure-Activity Relationship
Receptors, CXCR - agonists
Science & Technology
Styrene - chemical synthesis
Styrene - chemistry
Styrene - pharmacology
β-arrestin2
Title Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists
URI https://dx.doi.org/10.1016/j.ejmech.2012.02.041
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000304291900018
https://www.ncbi.nlm.nih.gov/pubmed/22424612
https://search.proquest.com/docview/1010485443
Volume 51
WOS 000304291900018
WOSCitedRecordID wos000304291900018
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CemihlDZ9OW0XFUJOcdcP2bKPwTRsWxpCk8DejCTLZZesd6k2h73kt3dGsrMJpLQUfLEl2UgznvmkeQEc6BZBu1Qm5FKlIc-5DmUU61CQx7tM8zR11vPvp_nkkn-dZtMdqIZYGHKr7GW_l-lOWvdPxv1qjlez2fgctQ-iB5TCiTMYUMAvR2WEPP3p5o6bR-7DULAzbbr4ED7nfLzMfGGcSYJOBPHi8Z_U09OVtLhora928RAcfVBzOS118hye9fCSHfsZvIAd0-3B42qo6rYHh2c-V_XmiF1sQ6_sETtkZ9ss1puXMD_fdAgO7QzbXLkc1HFMdg0jTegPEBkFRVDtCbZsmUUJ5N0OGmbpaLszoVzMGmOZtMwu5NVVuPC1eA2rptUPweTPJeXtta_g8uTzRTUJ-8IMoeZZscZ1TEoldaSSkhc6iVSbZDqPdKTLtslkKuOm1KIVSWtcch6VZYKbtNRK4HZPJulr2O2WnXkLrBRZKaOCp7louGljpQ1CPCVbo4WITBxAONCjXvn8G_XgmDavPf1qol8d4cWxvxiIVt_joxpVxF9Gju7R-PZzSVbkZG0M4ONA9BqJRoYV2ZnltaV3oiCkTIIBvPHcsB1N8TcIIwM4uMset-1uU4qgIKbqrXERQPwv3ao-gTslLljv__ec38ETuvMOnO9hd_3r2nxAkLVWI_cXjeDR8Zdvk9Pf9aQmAQ
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-69KGDMbbuy_voNCh9qok_JMt-LGYlXdtQ1hTyZiRZHgmNE6b0If_9TpLdrNCxMfCTJdtIJ9_9pLv7HcChahC0C6lDKmQa0oyqUESxCrmNeBdplqbOe345zkY39NuUTXeg7HNhbFhlp_u9Tnfaursz7GZzuJrNhtdofRA9oBZOnMMgfwK7lPGYDmD35Ox8NN5GemQ-EwX7230X7TPoXJiXni-080rYQ0G8aPwnC_VsJQzOW-MLXjyGSB81Xs5Qnb6A5x3CJCd-EC9hR7f7sFf2hd324ejK01Vvjslkm31ljskRudoSWW9ewfx60yI-NDNscxVz0MwR0dbEGkN_hkhsXoQtP0GWDTGohHzkQU2MPd1udSgWs1obIgwxC3F7Gy58OV5Nymn5nRPxY2mpe81ruDn9OilHYVebIVSU5Wucx6SQQkUyKWiukkg2CVNZpCJVNDUTqYjrQvGGJ412_DySMU51WijJcccnkvQNDNplq98BKTgrRJTTNOM11U0slUaUJ0WjFeeRjgMIe3lUK0_BUfWxafPKy6-y8qsivCj2573QqgdLqUIr8ZcnDx7I-P5zCcsz63AM4Esv9AqFZn0rotXLO2PfibrQkgkG8Navhu3TNgUHkWQAh78vj_t2ty9FXBDbAq5xHkD8L93KjsPdches3__3mD_D3mhyeVFdnI3PP8BT2-LjOT_CYP3zTn9CzLWWB90_9QsC1ii3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis%2C+modeling+and+functional+activity+of+substituted+styrene-amides+as+small-molecule+CXCR7+agonists&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Wijtmans%2C+Maikel&rft.au=Maussang%2C+David&rft.au=Sirci%2C+Francesco&rft.au=Scholten%2C+Danny+J&rft.date=2012-05-01&rft.eissn=1768-3254&rft.volume=51&rft.spage=184&rft_id=info:doi/10.1016%2Fj.ejmech.2012.02.041&rft_id=info%3Apmid%2F22424612&rft.externalDocID=22424612
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon